AcuCort’s new, innovative drug candidate enables fast uptake of the active ingredient. ISICORT® is not a tablet that must be swallowed nor does it require access to water since it is a fast-dissolving oral film to be put on the tongue. Important benefits in stressful situations such as acute and severe allergic reactions, not least for persons with swallowing difficulties.

What is AcuCort?

AcuCort develops and commercializes ISICORT® ‒ a new fast-dissolving oral film to be put on the tongue, based on a well-known version of cortisone – dexamethasone. ISICORT® is a smart product in a new, innovative and user-friendly administration form, primarily for the treatment of acute and severe allergic reactions, for croup in children and chemotherapy-induced nausea and vomiting (CINV).

The bioequivalence study that forms the basis of the application for marketing approval in Europe is carried out with positive results, which strengthens the assessment that the time until commercialization of ISICORT® may be relatively short. AcuCort (ticker: ACUC) is listed on the Spotlight Stock Market in Sweden.